APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $84,597,646 | +185.0% | 928,624 | +106.3% | 0.10% | +170.3% |
| Q1 2023 | $29,684,572 | +128694.6% | 450,039 | +1.0% | 0.04% | +12.1% |
| Q4 2022 | $23,048 | -100.0% | 445,705 | -54.9% | 0.03% | -67.0% |
| Q3 2022 | $67,450,000 | +52.6% | 987,567 | +1.0% | 0.10% | +63.9% |
| Q2 2022 | $44,210,000 | -3.1% | 977,658 | +8.9% | 0.06% | +17.3% |
| Q1 2022 | $45,625,000 | +49.3% | 897,956 | +38.9% | 0.05% | +73.3% |
| Q4 2021 | $30,560,000 | – | 646,359 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
| Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
| SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
| Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
| HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
| CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
| Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
| Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
| Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
| Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |